Add Company
Join Now

Yecuris Corporation Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Yecuris Corporation's estimated annual revenue is currently $5.4M per year.(i)
  • Yecuris Corporation's estimated revenue per employee is $155,000

Employee Data

  • Yecuris Corporation has 35 Employees.(i)
  • Yecuris Corporation grew their employee count by 35% last year.

Yecuris Corporation's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Project ManagerReveal Email/Phone
3
Operations ManagerReveal Email/Phone
4
In Vivo Production ManagerReveal Email/Phone
5
Senior Accounting ManagerReveal Email/Phone
6
Human Resources ManagerReveal Email/Phone
7
ControllerReveal Email/Phone
8
Biotechnology Sales AssociateReveal Email/Phone
9
Research associate 1Reveal Email/Phone
10
Research Assistant IIIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M11-54%N/AN/A
#2
$18.8M12111%N/AN/A
#3
$6.8M398%N/AN/A
#4
$0.8M40%N/AN/A
#5
$35.8M169-2%N/AN/A
#6
$1.7M7-22%N/AN/A
#7
$2.6M157%N/AN/A
#8
$0.8M40%N/AN/A
#9
$8.1M4812%N/AN/A
#10
$0.8M525%N/AN/A
Add Company

What Is Yecuris Corporation?

Whether you are building innovative gene therapies, targeting NASH, creating the next cure for a liver disease, or testing your small molecule for metabolism or toxicology, you need real data from from real human hepatocytes as early as possible. That’s why for more than a decade, researchers have trusted the FRG platform for their liver studies. Yecuris FRG are chimeric animal models with more than 70% of the liver replaced with human hepatocytes providing researchers with actionable insights into liver-specific questions at the cellular, tissue, and animal level.

keywords:N/A

N/A

Total Funding

35

Number of Employees

$5.4M

Revenue (est)

35%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.9M356%N/A
#2
$6.5M353%$2M
#3
$9.2M35-24%N/A
#4
$8.1M35-8%N/A
#5
N/A3540%N/A